Dyskinesia Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Dyskinesia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 27 trials

Recruiting

A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes

EpilepsyMovement DisordersNeurologic Disorder+7 more
Boston Children's Hospital500 enrolled1 locationNCT06585605
Recruiting

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

AsthmaChronic Obstructive Pulmonary DiseaseCystic Fibrosis+2 more
CHU de Reims470 enrolled1 locationNCT07274631
Recruiting
Phase 1

Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.

Gallstone DiseaseIrritable Bowel SyndromeGERD+2 more
Valenta Pharm JSC36 enrolled1 locationNCT07421011
Recruiting

DCP (RaDiCo Cohort) (RaDiCo-DCP)

Primary Ciliary Dyskinesia
Institut National de la Santé Et de la Recherche Médicale, France300 enrolled32 locationsNCT05951478
Recruiting
Not Applicable

Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia

HealthyPrimary Ciliary Dyskinesia
Indiana University40 enrolled1 locationNCT07288827
Recruiting
Not Applicable

Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD

Tardive DyskinesiaRepetitive Transcranial Magnetic Stimulation
Peking University Sixth Hospital62 enrolled1 locationNCT07173920
Recruiting

Living With Primary Ciliary Dyskinesia (Living With PCD)

Primary Ciliary Dyskinesia
University of Bern1,500 enrolled1 locationNCT04602481
Recruiting

The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)

Primary Ciliary DyskinesiaKartagener Syndrome
University of Bern1,000 enrolled1 locationNCT04611516
Recruiting
Not Applicable

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Parkinson DiseaseDystoniaTemporomandibular Joint Disorders+8 more
Massachusetts Eye and Ear Infirmary1,000 enrolled1 locationNCT05317390
Recruiting

Swiss Primary Ciliary Dyskinesia Registry

Primary Ciliary DyskinesiaKartagener Syndrome
University of Bern800 enrolled1 locationNCT03606200
Recruiting
Not Applicable

Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia

Primary Ciliary Dyskinesia
Instituto Nacional de Enfermedades Respiratorias60 enrolled1 locationNCT06959251
Recruiting
Phase 4

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

SchizophreniaMajor Depressive DisorderBipolar Disorder+2 more
Neurocrine Biosciences50 enrolled8 locationsNCT07105111
Recruiting

Utility of PCD Diagnostics to Improve Clinical Care

Primary Ciliary Dyskinesia
Connecticut Children's Medical Center50 enrolled1 locationNCT05889013
Recruiting

Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)

Quality of LifeIdiopathic Parkinson DiseaseDyskinesias
Izmir Bakircay University130 enrolled2 locationsNCT07023224
Recruiting

Registry and Natural History of Epilepsy-Dyskinesia Syndromes

DyskinesiaEpilepsyMovement Disorders+11 more
Boston Children's Hospital700 enrolled1 locationNCT06967727
Recruiting
Phase 2

Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia

Biliary DyskinesiaChronic Cholecystitis
Valenta Pharm JSC300 enrolled17 locationsNCT06842966
Recruiting
Not Applicable

Utility of PCD Diagnostics to Improve Clinical Care

Primary Ciliary Dyskinesia
Vanderbilt University Medical Center200 enrolled1 locationNCT03704207
Recruiting
Not Applicable

Thermal Spa Treatment and Improvement of Primary Ciliary Dyskinesia

Primary Ciliary Dyskinesia
Association Francaise pour la Recherche Thermale35 enrolled1 locationNCT07029594
Recruiting
Not Applicable

Neural Correlates of Movement Disorders Associated With PRRT2 Related Paroxysmal Kinesigenic Dyskinesia - an Ancillary Study of AMEDYST Research

Paroxysmal Dyskinesia
Institut National de la Santé Et de la Recherche Médicale, France1 enrolled1 locationNCT06701851
Recruiting

Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

Primary Ciliary Dyskinesia
Arkansas Children's Hospital Research Institute150 enrolled1 locationNCT05287022